Sagility Q1 Results FY27: Net Profit Soars 45.9% to Rs 216 Crore on Strong Healthcare Services Demand

Sagility Q1 FY27: consolidated PAT Rs 216 Cr, up 45.9% YoY. Revenue Rs 1,963 Cr, up 27.6%. Gross profit up 36.1% at Rs 310 Cr. Shares trading down 0.10% as of 22 July 2026.

Sagility Q1 results FY27 were announced on Tuesday, 21 July 2026, with the company reporting the numbers summarised below on a consolidated basis for the quarter ended 30 June 2026.

Shares of Sagility were trading down 0.10 at Rs 41.80 on the NSE as of Wednesday, 22 July 2026. The healthcare focused business process management company delivered profit growth well ahead of revenue growth, a broad based beat.

Click Here – Get Free Investment Predictions

Sagility Q1 Results FY27 Key Takeaways

Here are the most important numbers from the June 2026 quarter at a glance.

• Revenue: Rs 1,963 Cr in Q1 FY27 versus Rs 1,538 Cr in Q1 FY26, up 27.6% year on year.
• Gross Profit: Rs 310 Cr in Q1 FY27 versus Rs 227 Cr in Q1 FY26, up 36.1% year on year.
• Net Profit (PAT): Rs 216 Cr in Q1 FY27 versus Rs 148 Cr in Q1 FY26, up 45.9% year on year.
• Sagility shares were trading down 0.10 at Rs 41.80 as of Wednesday, 22 July 2026.

Sagility Q1 Results FY27 Financial Highlights

The table below summarises the consolidated numbers reported in the Sagility Q1 results FY27 against the year ago quarter.

All figures are on a consolidated basis as reported for the quarter ended 30 June 2026.

Sagility Q1 Results FY27 Performance Analysis

Get Personalised Guidance from a SEBI-Registered Investment Advisor

The Sagility Q1 results FY27 show textbook operating leverage. Revenue grew 27.6%, gross profit grew faster at 36.1%, and net profit grew fastest at 45.9%, with each line accelerating down the P&L, a pattern that reflects both scale efficiency and disciplined cost management.

For a healthcare business process management company serving US payer and provider clients, revenue growth of this magnitude typically reflects both new client wins and expansion within existing accounts, while the margin expansion visible in the Sagility Q1 results FY27 suggests offshore delivery efficiency and operating leverage as the client base scales.

The stock trading essentially flat despite this strong beat is somewhat unusual, and may reflect the stock having already priced in strong growth expectations, or broader market conditions on the day offsetting company specific positive news.

Sagility Q1 Results FY27: Key Business Factors

1. Broad Based Acceleration Down the P&L

Revenue, gross profit and net profit growth accelerating from 27.6% to 36.1% to 45.9% respectively in the Sagility Q1 results FY27 is a clean signal of operating leverage and cost discipline.

2. Healthcare BPM Demand Strength

Strong revenue growth points to continued demand for outsourced healthcare business process management services from US payers and providers.

3. Muted Stock Reaction Despite the Beat

Shares trading roughly flat despite the strong Sagility Q1 results FY27 suggests the positive news may already be reflected in the stock price, or broader market factors offset the company specific beat.

Dividend Details

Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company’s official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.

Sagility Q1 Results FY27 Outlook for the Full Year

After the Sagility Q1 results FY27, the key markers for FY27 are continued client wins, expansion of service lines within existing healthcare payer and provider accounts, and whether the margin expansion trajectory can be sustained as the company scales further.

Sagility Stock Performance After the Q1 Results

Download the Univest iOS App or Univest Android App to track Sagility live share price and upcoming quarterly results.

Sagility shares were trading down 0.10 at Rs 41.80 on the NSE as of Wednesday, 22 July 2026, a day after the Sagility Q1 results FY27 were announced.

Investors can compare the trend of the counter with the Nifty 500 index to judge how the stock is placed relative to the broader market after the June quarter results.

Key Risks

Investors going through the fine print of the Sagility Q1 results FY27 should also weigh the following risks.

1. Client Concentration in US Healthcare

As a healthcare BPM provider focused on the US market, the business carries client concentration and regulatory exposure specific to US healthcare payers and providers.

2. Currency and Offshore Delivery Risk

With delivery likely spanning offshore centres serving US clients, currency fluctuations and offshore cost trends can affect margins.

3. Sustaining the Pace of Margin Expansion

The acceleration from revenue to profit growth in the Sagility Q1 results FY27 sets a high bar. Any moderation in this operating leverage trend could disappoint elevated expectations.

Conclusion

Sagility Q1 results FY27 show a broad based beat with net profit up 45.9% at Rs 216 crore, revenue up 27.6% and gross profit up 36.1%, though the stock traded roughly flat. Investors should track client wins and margin sustainability into FY27 and consult a SEBI-registered advisor before acting on the numbers.

Frequently Asked Questions on Sagility Q1 Results FY27

When were the Sagility Q1 results FY27 announced?

Ans. The Sagility Q1 results FY27 were announced on Tuesday, 21 July 2026, for the quarter ended 30 June 2026, on a consolidated basis.

What is the PAT in the Sagility Q1 results FY27?

Ans. The consolidated PAT in the Sagility Q1 results FY27 stood at Rs 216 crore, up 45.9% from Rs 148 crore in Q1 FY26.

What was the revenue in the Sagility Q1 results FY27?

Ans. Revenue in the Sagility Q1 results FY27 stood at Rs 1,963 crore, up 27.6% from Rs 1,538 crore in Q1 FY26.

What was the gross profit in the Sagility Q1 results FY27?

Ans. Gross profit in the Sagility Q1 results FY27 stood at Rs 310 crore, up 36.1% from Rs 227 crore in Q1 FY26.

What does Sagility do?

Ans. The company provides business process management services focused on the healthcare sector, serving payers and providers primarily in the United States.

How is the stock trading after the Sagility Q1 results FY27?

Ans. Sagility shares were trading down marginally at 0.10% at Rs 41.80 on the NSE as of Wednesday, 22 July 2026, a day after the Sagility Q1 results FY27 were announced.

Is the stock a good buy after the Sagility Q1 results FY27?

Ans. The Sagility Q1 results FY27 show a broad based beat with accelerating growth down the P&L, though client concentration in US healthcare is a factor to weigh. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.

Where can I verify the Sagility Q1 results FY27?

Ans. The official filings for the June 2026 quarter are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.